The PD-1/PD-L pathway is up-regulated during IL-12-induced suppression of EAE mediated by IFN-gamma

Journal of Neuroimmunology

Volumn 185, Issue 1-2, 2007, Pages 75-86

  Cheng, Xiaodong ^a,b   Zhao, Zhao ^a   Ventura, Elvira ^a   Gran, Bruno ^a   Shindler, Kenneth S ^c   Rostami, Abdolmohamad ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b BLOOD RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antigen presenting cells; Autoimmunity; Cytokines; EAE; PD 1 PD L

Indexed keywords

B7 ANTIGEN; CD11B ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN[35-55]; PROGRAMMED DEATH 1 LIGAND; PROGRAMMED DEATH 1 PROTEIN; RECOMBINANT INTERLEUKIN 12; UNCLASSIFIED DRUG;

ADOLESCENT; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; FEMALE; IMMUNOMODULATION; MOLECULAR INTERACTION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GLYCOPROTEINS; INTERFERON TYPE II; INTERLEUKIN-12; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 33947706258     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.01.012     Document Type: Article

References (62)

1. Agata Y., Kawasaki A., Nishimura H., Ishida Y., Tsubata T., Yagita H., and Honjo T. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 8 (1996) 765-772
2. Aggarwal S., Ghilardi N., Xie M.H., Sauvage F.J.d., and Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278 (2003) 1910-1914
3. Begolka W.S., Vanderlugt C.L., Rahbe S.M., and Miller S.D. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis. J. Immunol. 161 (1998) 4437-4446
4. Benson J.M., Campbell K.A., Guan Z., Gienapp I.E., Stuckman S.S., Forsthuber T., and Whitacre C.C. T-cell activation and receptor downmodulation precede deletion induced by mucosally administered antigen. J. Clin. Invest. 106 (2000) 1031-1038
5. Billiau A., Heremans H., Vandekerckhove F., Dijkmans R., Sobis H., Meulepas E., and Carton H. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J. Immunol. 140 (1988) 1506-1510
6. Brown J., Dorfman D.M., Ma F., Sullivan E.L., Munoz O., Wood C.R., Greenfield E.A., and Freeman G.J. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 170 (2003) 1257-1266
7. Cai G., Karni A., Oliveira E.M.L., Weiner H.L., Hafler D.A., and Freeman G.J. PD-1 ligands, negative regulators for activation of naïve, memory, and recently activated human CD4+ T cells. Cell. Immunol. 230 (2004) 89-98
8. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., Zurawski S., Wiekowski M., Lira S.A., Gorman D., Kastelein R.A., and Sedgwick J.D. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421 (2003) 744-748
9. Dong H., Zhu G., Tamada K., and Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5 (1999) 1365-1369
10. Duong T.T., St. Louis J., Gilbert J.J., Finkelman F.D., and Strejan G.H. Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J. Neuroimmunol. 36 (1992) 105-115
11. Eppihimer M.J., Gunn J., Freemen G.J., Greenfield E.A., Chernova T., Erickson J., and Leonard J.P. Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells. Microcirculation 9 (2002) 133-145
12. Ferber I.A., Brocke S., Taylor-Edwards C., Ridgway W., Dinisco C., Steinman L., Dalton D., and Fathman C.G. Mice with a disrupted IFN-γ gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156 (1996) 5-7
13. Gately M.K., Desai B.B., Wolitzky A.G., Quinn P.M., Dwyer C.M., Podlaski F.J., Familletti P.C., Sinigaglia F., Chizonnite R., and Gubler U. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J. Immunol. 147 (1991) 874-882
14. Gran B., Zhang G.X., Yu S., Li J., Chen X.H., Ventura E.S., Kamoun M., and Rostami A.M. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol. 169 (2002) 7104-7110
15. Gran B., Zhang G.X., and Rostami A.M. Role of the IL-12/IL-23 system in the regulation of T-cell responses in central nervous system inflammatory demyelination. Crit. Rev. Immunol. 24 (2004) 111-128
16. Gran B., Chu N., Zhang G.X., Yu S., Li Y., Chen X.H., Kamoun M., and Rostami A.M. Early administration of IL-12 suppresses EAE through induction of interferon-γ. J. Neuroimmunol. 156 (2004) 123-131
17. Greenwald R.J., Boussiotis V.A., Lorsbach R.B., Abbas A.K., and Sharpe A.H. CTLA-4 regulates induction of anergy in vivo. Immunity 14 (2001) 145-155
18. Hammerberg C., Duraiswamy N., and Cooper K.D. Reversal of immunosuppression inducible through ultraviolet-exposed skin by in vivo anti-CD11b treatment. J. Immunol. 157 (1996) 5254-5261
19. Heremans H., Dillen C., Groenen M., Martens E., and Billiau A. Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon-gamma. Eur. J. Immunol. 26 (1996) 2393-2398
20. Ingham D.J., Beer S., Money S., and Hamsen G. Quantitative real-time PCR assay for determining transgene copy number in transformed plants. Biotechniques 31 132-134 (2001) 136-140
21. Khoury S.J., and Sayegh M.H. The roles of the new negative T cell costimulatory pathways in regulating autoimmunity. Immunity 20 (2004) 529-538
22. Kobayashi M., Fitz L., Ryan M., Hewrick R.M., Clark S.C., Chan S., Loudon R., Sherman F., Perussia B., and Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170 (1989) 827-845
23. Kohm A.P., Carpentier P.A., Anger H.A., and Miller S.D. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169 (2002) 4712-4716
24. Krakowski M., and Owens T. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26 (1996) 1641-1646
25. Langrish C.L., McKenzie B.S., Wilson N.J., Malefyt R.W., Kastelein R.A., and Cua D.J. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rew. 202 (2004) 96-105
26. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., and Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201 (2005) 233-240
27. Latchman Y., Wood C.R., Chernova T., Chaudhary D., Borde M., Chernova I., Iwai Y., Long A.J., Brown J.A., Nunes R., Greenfield E.A., Bourque K., Boussiotis V.A., and Carter L.L. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2 (2001) 261-268
28. Latchman Y.E., Liang S.C., Wu Y., Chernova T., Sobel R.A., Klemm M., Kuchroo V.K., Freeman G.J., and Sharpe A.H. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc. Natl. Acad. Sci. 101 (2004) 10691-10696
29. Lechner O., Lauber J., Franzke A., Sarukhan A., von Boehmer H., and Buer J. Fingerprints of anergic T cells. Curr. Biol. 8 (2001) 587-595
30. Li J., Gran B., Zhang G.X., Rostami A.M., and Kamoun M. IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis. J. Neurol. Sci. 232 (2005) 3-9
31. Liang S.C., Latchman Y.E., Buhlmann J.E., Tomczak M.F., Horwitz B.H., Freeman G.J., and Sharpe A.H. Regulation of PD-1, PD-L1, PD-L2 expression during normal and autoimmune responses. Eur. J. Immunol. 33 (2003) 2706-2716
32. T method. Methods 25 (2001) 402-408
33. Loke P., and Allison J.P. PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. Proc. Natl. Acad. Sci. 100 (2003) 5336-5341
34. Loza M.J., and Perussia B. Peripheral immature CD2-/low T cell development from type 2 to type 1 cytokine production. J. Immunol. 169 (2002) 3061-3068
35. Lublin F.D., Knobler R.L., Kalman B., Goldhaber M., Marini J., Perrault M., D'Imperio C., Joseph J., Alkan S.S., and Korngold R. Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis. Autoimmunity 16 (1993) 267-274
36. Ma X., and Trinchieri G. Regulation of interleukin-12 production in antigen-presenting cells. Adv. Immunol. 79 (2001) 55-92
37. Matusevicius D., Kivisakk P., He B., Kostulas N., Ozenci V., Fredrikson S., and Link H. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult. Scler. 5 (1999) 101-104
38. Mullen A.C., High F.A., Hutchins A.S., Lee H.W., Villarino A.V., Livingston D.M., Kung A.L., Cereb N., Yao T.P., Yang S.Y., and Reiner S.L. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 292 (2001) 1907-1910
39. Nishimura H., Okazaki T., Tanaka Y., Nakatani K., Hara M., Matsumori A., Sasayama S., Mizoguchi A., Hiai A., Minato N., and Honjo T. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291 (2001) 319-322
40. Okazaki T., Iwai Y., and Homjo T. New regulatory co-receptors: inducible co-stimulator and PD-1. Curr. Opin. Immunol. 14 (2002) 779-782
41. Salama A.D., Chitnis T., Imitola J., Akiba H., Tushima F., Azuma M., Yagita H., Sayagh M.H., and Khoury S.J. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 198 (2003) 71-78
42. Schlecht G., Loucka J., Najar H., Sebo P., and Leclerc C. Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming. J. Immunol. 173 (2004) 6089-6097
43. Schoop R., Wahl P., Hir M.L., Heemann U., Wang M., and Wuethrich R.P. Suppressed T-cell activation by IFN-γ-induced expression of PD-L1 on renal tubular epithelial cells. Nephrol. Dial. Transplant. 19 (2004) 2713-2720
44. Segal B.M., Dwyer B.K., and Shevach E.M. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187 (1998) 537-546
45. Sharpe A.H., and Freeman G.J. The B7-CD28 superfamily. Nat. Rev. Immunol. 2 (2002) 116-126
46. Song P., Cai C., Skokut M., Kosegi B., and Petolino J. Quantitative real-time PCR as a screening tool for estimating transgene copy number in WHISKERS™-derived transgenic maize. Plant Cell Rep. 20 (2002) 948-954
47. Steinman L. Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron 24 (1999) 511-514
48. Storek J., Zhao Z., Lin E., Berger T., McSweeney P.A., Nash R.A., Akatsuka Y., Metcalf M.D., Lu H., and Kalina T. Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune dieases). Clin. Immunol. 113 (2004) 285-298
49. Stumhofer J.S., Laurence A., Wilson E.H., Huang E., Tato C.M., John L.M., Villarino A.V., Huang Q., Yoshimura A., Sehy D., Saris C.J., O'shea J.J., Hennighausen L., Ernst M., and Hunter C.A. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7 (2006) 937-945
50. Tanuma N., Shin T., Kogure K., and Matsumoto Y. Differential role of TNF-alpha and IFN-gamma in the brain of rats with chronic relapsing autoimmune encephalomyelitis. J. Neuroimmunol. 96 (1999) 73-79
51. Trinchieri G., and Scott P. Interleukin-12; a proinflammatory cytokine with immunoregulatory functions. Res. Immunol. 146 (1995) 423-431
52. Trinchieri G., Pflanz S., and Kastelein R.A. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19 (2003) 641-644
53. Voorthuis J.A., Uitdehaag B.M., De Groot C.J., Goede P.H., Meide P.H., and von der Dijkstra C.D. Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats. Clin. Exp. Immunol. 81 (1990) 183-188
54. Wekerle H., Kojima K., Lannes-Vieira J., Lassmann H., and Linington C. Animal models. Ann. Neurol. 36l (1994) S47-S53
55. Willenborg D.O., Fordham S., Bernard C.C., Cowden W.B., and Ramshaw I.A. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157 (1999) 3223-3227
56. Wu C.Y., Kirman J.R., Rotte M.J., Davey D.F., Perfetto S.P., Rhee E.G., Freidag B.L., Hill B.J., Douek D.C., and Seder R.A. Distinct lineages of T(H)1 cells have differential capacities for memory cell generation in vivo. Nat. Immunol. 3 (2002) 852-858
57. Wu H., Rodgers J.R., Perrard X.Y., Perrard J.L., Prince J.E., Abe Y., Davis B.K., Dietsch G., Smith C.W., and Ballantyne C.M. Deficient of CD11b or CD11d results in reduced staphylococcal enterotoxin-induced T cell response and T cell phenotypic Changes. J. Immunol. 173 (2004) 297-306
58. Yamazaki T., Akiba H., Iwai H., Matsuda H., Aoki M., Tanno Y., Shin T., Tsuchiya H., Pardoll D.M., Okumura K., Azuma M., and Yagita H. Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 169 (2002) 5538-5545
59. Zhang G.X., Gran B., Yu S., Li J., Siglienti I., Chen X., Kamoun M., and Rostami A.M. Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-β2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system. J. Immunol. 170 (2003) 2153-2160
60. Zhang G.X., Yu S., Gran B., Li J., Siglienti I., Chen X., Calida D., Ventura E., Kamoun M., and Rostami A.M. Role of IL-12 receptor β1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis. J. Immunol. 171 (2003) 4485-4492
61. Zhu B., Guleria I., Khosroshahi A., Chitnis T., Imitola J., Azuma M., Yagita H., Sayegh M.H., and Khoury S.J. Differential role of programmed death-ligand 1 and programmed death-ligand 2 in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis. J. Immunol. 176 (2006) 3480-3489
62. Ziolkowska M., Koc A., Luszczykiewicz G., Ksiezopolska-Pietrzak K., Klimczak E., Chwalinska-Sadowska H., and Maslinski W. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J. Immunol. 164 (2000) 2832-2838